Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 18c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Zimmer Biomet (ZBH) PT Raised to $188 at Truist Securities Following Earnings
May 4, 2021 2:01 PM EDTTruist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining a Buy rating.
The analyst commented, "Zimmer Biomet reported 1Q21 results with both revenue and adj. EPS above consensus. After focusing on the spinoff last quarter,... More
Zimmer Biomet (ZBH) PT Raised to $202 at Needham & Company Following Earnings
May 4, 2021 2:00 PM EDTNeedham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $202.00 (from $192.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 1Q21 revenue and EPS beat consensus. ZBH's underlying revenue growth improved in 1Q21, which we believe was... More
Wells Fargo Introduces 35 "Signature Picks" - Here's Which Stocks Made It
May 3, 2021 7:17 AM EDTChristopher Harvey, a senior research analyst at Wells Fargo, unveiled today the "Signature Picks" portfolio consisting of 35 stocks.
A portfolio, accessible under the Bloomberg ticker WFSSBEST Index, highlighting the banks "best stock ideas in a diversified, risk-adjusted package." The goal is to outperform the S&P500 over a 1-year period via stock selection, not sector rotation, Harvey writes in a note.
Signature Picks has no preordained style/factor biases (unlike our former model portfolio, the QQP). It is designed to be an eclectic/opportunistic portfolio with a... More
